Long-term physical activity modulates adipsin and ANGPTL4 serum levels, a potential link to exercise-induced metabolic changes. 2023

Max Lenz, and Robert Schönbauer, and Stefan Stojkovic, and Michael Lichtenauer, and Vera Paar, and Constantin Gatterer, and Christoph Schukro, and Michael Emich, and Monika Fritzer-Szekeres, and Jeanette Strametz-Juranek, and Michael Sponder
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria - Max.Lenz@meduniwien.ac.at.

BACKGROUND Within the presented prospective study, we aimed to illuminate the effect of long-term physical exercise on serum levels of adipsin (complement factor D) and angiopoietin-like 4 (ANGPTL4). Although past studies already outlined the effects of acute exercise, our trial design aimed to depict the development under long-term physical activity conditions. METHODS Ninety-eight participants were included in the study and were asked to perform eight months of moderate physical activity for at least 150 minutes/week and/or vigorous-intensity exercise for at least 75 minutes/week. According to initial performance and performance gain throughout the study period, four groups were formed and subsequently compared. Blood sampling for the determination of routine laboratory parameters was done at baseline, after 2, 6, and 8 months. Additionally, adipsin and ANGPTL4 serum levels were concurrently quantified using commercially available ELISA kits. RESULTS The study cohort consisted of 61.2% male participants with an average age of 49.3±6.7 years. Adipsin and ANGPTL4 were found to be strongly increased by long-term physical exercise. Participants displaying a performance gain of >2.9% throughout the study showed significantly increased serum levels of both biomarkers. CONCLUSIONS Serum levels of adipsin and ANGPTL4 were closely tied to the individual performance gain of the participating probands. An association of adipsin levels, initial performance, and serum triglycerides was found at baseline. Interestingly, this interrelationship was not detectable after eight months of physical training. This finding might indicate adipsin's involvement in linking triglyceride-balance to individual performance and energy demands in a homeostatic state.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011416 Complement Factor D A serum protein which is important in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. This enzyme cleaves the COMPLEMENT C3B-bound COMPLEMENT FACTOR B to form C3bBb which is ALTERNATIVE PATHWAY C3 CONVERTASE. Adipsin,C3 Convertase Activator,C3PA Convertase,Factor D,Properdin Factor D,28 kDa Protein, Adipocyte,C3 Proactivator Convertase,C3PAse,Complement Protein D,D Component of Complement,GBGase,Proactivator Convertase,Activator, C3 Convertase,Complement D Component,Convertase Activator, C3,Convertase, C3 Proactivator,Convertase, C3PA,Convertase, Proactivator,Factor D, Complement,Factor D, Properdin,Protein D, Complement
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075803 Angiopoietin-Like Protein 4 A secreted angiopoietin-like protein expressed under hypoxic conditions by ENDOTHELIAL CELLS. It inhibits cell proliferation, cell migration, and tubule formation; the inactive form accumulates in the endothelial EXTRACELLULAR MATRIX, reducing vascular leakage. ANGPTL4 has direct roles in regulating glucose and lipid metabolism, as well as INSULIN SENSITIVITY, and may also function as a regulator of angiogenesis and tumorigenesis. ANGPTL4 Protein,Angiopoietin-related Protein 4,4, Angiopoietin-Like Protein,Angiopoietin Like Protein 4,Angiopoietin related Protein 4,Protein 4, Angiopoietin-Like
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Max Lenz, and Robert Schönbauer, and Stefan Stojkovic, and Michael Lichtenauer, and Vera Paar, and Constantin Gatterer, and Christoph Schukro, and Michael Emich, and Monika Fritzer-Szekeres, and Jeanette Strametz-Juranek, and Michael Sponder
March 1970, Clinica chimica acta; international journal of clinical chemistry,
Max Lenz, and Robert Schönbauer, and Stefan Stojkovic, and Michael Lichtenauer, and Vera Paar, and Constantin Gatterer, and Christoph Schukro, and Michael Emich, and Monika Fritzer-Szekeres, and Jeanette Strametz-Juranek, and Michael Sponder
January 2017, PloS one,
Max Lenz, and Robert Schönbauer, and Stefan Stojkovic, and Michael Lichtenauer, and Vera Paar, and Constantin Gatterer, and Christoph Schukro, and Michael Emich, and Monika Fritzer-Szekeres, and Jeanette Strametz-Juranek, and Michael Sponder
September 1996, Biological psychology,
Max Lenz, and Robert Schönbauer, and Stefan Stojkovic, and Michael Lichtenauer, and Vera Paar, and Constantin Gatterer, and Christoph Schukro, and Michael Emich, and Monika Fritzer-Szekeres, and Jeanette Strametz-Juranek, and Michael Sponder
August 2018, Heart and vessels,
Max Lenz, and Robert Schönbauer, and Stefan Stojkovic, and Michael Lichtenauer, and Vera Paar, and Constantin Gatterer, and Christoph Schukro, and Michael Emich, and Monika Fritzer-Szekeres, and Jeanette Strametz-Juranek, and Michael Sponder
November 1997, European journal of clinical investigation,
Max Lenz, and Robert Schönbauer, and Stefan Stojkovic, and Michael Lichtenauer, and Vera Paar, and Constantin Gatterer, and Christoph Schukro, and Michael Emich, and Monika Fritzer-Szekeres, and Jeanette Strametz-Juranek, and Michael Sponder
January 2013, Circulation,
Max Lenz, and Robert Schönbauer, and Stefan Stojkovic, and Michael Lichtenauer, and Vera Paar, and Constantin Gatterer, and Christoph Schukro, and Michael Emich, and Monika Fritzer-Szekeres, and Jeanette Strametz-Juranek, and Michael Sponder
February 2016, Scientific reports,
Max Lenz, and Robert Schönbauer, and Stefan Stojkovic, and Michael Lichtenauer, and Vera Paar, and Constantin Gatterer, and Christoph Schukro, and Michael Emich, and Monika Fritzer-Szekeres, and Jeanette Strametz-Juranek, and Michael Sponder
December 2019, Endocrinology,
Max Lenz, and Robert Schönbauer, and Stefan Stojkovic, and Michael Lichtenauer, and Vera Paar, and Constantin Gatterer, and Christoph Schukro, and Michael Emich, and Monika Fritzer-Szekeres, and Jeanette Strametz-Juranek, and Michael Sponder
April 1970, Arztliche Forschung,
Max Lenz, and Robert Schönbauer, and Stefan Stojkovic, and Michael Lichtenauer, and Vera Paar, and Constantin Gatterer, and Christoph Schukro, and Michael Emich, and Monika Fritzer-Szekeres, and Jeanette Strametz-Juranek, and Michael Sponder
January 2019, PeerJ,
Copied contents to your clipboard!